RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Quintiles today announced that it has completed the acquisition
of Encore
Health Resources (Encore), a leader in the health-information
analytics and technology consulting services industry focused on
healthcare providers.
“We are extremely pleased to have completed the acquisition of Encore,”
said Scott Evangelista, president, Integrated Commercial Services and
Solutions at Quintiles. “The addition of Encore greatly enhances our
electronic health records expertise – an area that continues to grow in
importance as payers, providers and biopharmaceutical customers increase
their focus on real-world evidence. We are excited about working
together with the Encore team and leveraging the expertise each
organization possesses to help our customers improve their probability
of success.”
Now known as “Encore, A Quintiles Company,” Encore will operate as part
of Quintiles’ Integrated Healthcare Services segment.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest
provider of biopharmaceutical development and commercial outsourcing
services. With a network of more than 29,000 employees conducting
business in approximately 100 countries, we helped develop or
commercialize all of 2013’s top-100 best-selling drugs on the market.
Quintiles applies the breadth and depth of our service offerings along
with extensive therapeutic, scientific and analytics expertise to help
our customers navigate an increasingly complex healthcare environment as
they seek to improve efficiency and effectiveness in the delivery of
better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Forward-Looking Statements
This press release may contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934. Such forward-looking statements
reflect, among other things, Quintiles’ current expectations and
anticipated results of operations, all of which are subject to known and
unknown risks, uncertainties and other factors that may cause Quintiles’
actual results, performance or achievements, market trends, or industry
results to differ materially from those expressed or implied by such
forward-looking statements. Therefore, any statements contained herein
that are not statements of historical fact may be forward-looking
statements and should be evaluated as such. Without limiting the
foregoing, the words “anticipates,” “believes,” “estimates,” “expects,”
“intends,” “may,” “plans,” “projects,” “should,” “guidance,” “targets,”
“will” and the negative thereof and similar words and expressions are
intended to identify forward-looking statements. These statements are
subject to risks, uncertainties and assumptions, including our ability
to complete, integrate and achieve our intended objectives with respect
to the proposed acquisition of Encore and those described under the
section entitled "Risk Factors" in Quintiles’ annual report on Form 10-K
for the fiscal year ended December 31, 2013, filed with the SEC on
February 13, 2014, as such factors may be updated from time to time in
Quintiles’ periodic filings with the SEC, which are accessible on the
SEC's website at www.sec.gov.
These factors should not be construed as exhaustive and should be read
in conjunction with the other cautionary statements that are included in
this release and in Quintiles’ filings with the SEC. Unless legally
required, Quintiles assumes no obligation to update any such
forward-looking statement after the date of this release, whether as a
result of new information, future developments or otherwise.
Click here
to subscribe to Mobile Alerts for Quintiles.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140701006481/en/
Source: Quintiles